Revolution Medicines · 21 hours ago
Associate Director, Medical Affairs Content and Training
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Associate Director of Medical Affairs Content and Training will shape the training and content roadmap for the team, ensuring effective communication of scientific data and preparation for product launches in oncology.
Health CareLife ScienceMedical
Responsibilities
Lead development and execution of select global Medical Affairs content and training plans
Execute a comprehensive Medical Affairs tactical training roadmap to ensure scientific fluency across the organization
Provide input on decisions and implementation strategy and manage actions that impact the team's budget
Support the implementation of scientific training programs for new hires and ongoing scientific training for MSLs and other Medical Affairs functions
Prepare training curricula to enhance therapeutic area expertise, scientific knowledge, external engagement skills, and competitive insights
Organize scientific deep dives, medical education forums, and training workshops to maintain a high level of scientific competency within Medical Affairs
Ensure training programs are adaptable to different levels of scientific expertise within the team and align with product lifecycle milestones
Implement training assessments to measure the effectiveness of scientific learning and identify areas for continuous improvement
Lead the creation of select scientific materials to support external engagements, including MSL decks, infographics, videos, and training guides
Collaborate with internal stakeholders (Medical Strategy, Medical Communications, Clinical Development, Regulatory, Commercial, Legal, Compliance) to ensure medical content is aligned with company strategy and meets regulatory and legal requirements
Partner with Medical Affairs leadership to develop a structured pre-launch training plan, ensuring the team is scientifically prepared to support product launch
Work closely with Field Medical/MSL teams to ensure alignment between scientific training, medical content, and external engagement strategy
Work closely with Medical Excellence, Field Medical, Medical Communications, Medical Information, and Medical Strategy teams to align on training priorities and content needs
Support cross-functional meetings to assess training needs and ensure scientific alignment across the organization
Collaborate with vendor partners to manage development and execution of various deliverables
Qualification
Required
Advanced scientific or medical degree (PhD, PharmD, MD)
5-7+ years of experience in Medical Affairs, Scientific Training, or Medical Communications within the biotechnology or pharmaceutical industry
Strong expertise in scientific content development and training program design for Medical Affairs teams
Demonstrated ability to translate complex scientific data into clear, engaging, and compliant medical content for various stakeholders
Experience developing scientific training curricula, onboarding programs, and continuous learning initiatives
Proven ability to work cross-functionally with Field Medical, Medical Information, Medical Communications, and Commercial teams to develop consistent messaging and training programs
Strong oncology experience preferred, particularly in precision medicine, targeted therapies, or RAS/oncogene-driven cancers
Deep understanding of industry guidelines (e.g., PhRMA Code, OIG, ACCME, FDA, and other global regulatory requirements) for scientific content and training
Ability to thrive in a fast-paced, evolving biotech environment, managing multiple priorities effectively
Excellent communication, presentation, and interpersonal skills, with the ability to engage with diverse internal and external audiences
Preferred
Prior oncology launch experience in Medical Affairs training and scientific content development
Familiarity with digital training platforms, virtual learning solutions, and e-learning modules
Experience with MSL engagement strategies, medical education planning, and congress preparation
Understanding of emerging trends in scientific communication, digital learning, and knowledge management
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase